Gut Microbiota and its impact on the inflammation-dysplasia-cancer sequence

1 Karpiński TM, Ożarowski M, Stasiewicz M. Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 2022;86(Pt3):420-430; DOI:10.1016/j.semcancer.2022.01.004. Search in Google Scholar

2 Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254; DOI:10.3322/caac.21772. Search in Google Scholar

3 Wojciechowska U, Baranska K, Michalek I, Olasek P, Miklewska M, Didkowska JA. Zachorowania i zgony na nowotwory złośliwe w Polsce. [Internet]. Warszawa: Polish National Cancer Registry; 2020 [cited 2023 Feb 08] 100 p. Available from: https://onkologia.org.pl/sites/default/files/publications/2023-01/nowotwory_2020.pdf. Search in Google Scholar

4 Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020;11:615056; DOI:10.3389/fimmu.2020.615056. Search in Google Scholar

5 Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022;28(30):4053-4060; DOI:10.3748/wjg.v28. i30.4053. Search in Google Scholar

6 Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2022;12:807648; DOI:10.3389/fimmu.2021.807648. Search in Google Scholar

7 Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904; DOI:10.1152/physrev.00045.2009. Search in Google Scholar

8 Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol (NY). 2013;9(9):560-569. Search in Google Scholar

9 Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J Neuroimmunol. 2019;328:98-104; DOI:10.1016/j. jneuroim.2019.01.004. Search in Google Scholar

10 Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer. 2021;21(1):1325; DOI:10.1186/s12885-021-09054-2. Search in Google Scholar

11 Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16(11):690-704; DOI:10.1038/s41575-019-0209-8. Search in Google Scholar

12 DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137-1150; DOI:10.1097/MIB.0000000000000750. Search in Google Scholar

13 Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94; DOI:10.3389/fphys.2011.00094. Search in Google Scholar

14 Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377-388; DOI:10.1038/s41591-019-0377-7. Search in Google Scholar

15 Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011;3(6):637-682. DOI: 10.3390/nu3060637. Search in Google Scholar

16 Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The Gut microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020;17(20):7618; DOI:10.3390/ijerph17207618. Search in Google Scholar

17 Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019-2040; DOI:10.1007/s10482-020-01474-7. Search in Google Scholar

18 Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008;14(25):3937-3947; DOI:10.3748/wjg.14.3937. Search in Google Scholar

19 Freeman HJ. Colorectal cancer risk in Crohn’s disease. World J Gastroenterol. 2008;14(12):1810-1811; DOI:10.3748/wjg.14.1810. Search in Google Scholar

20 Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. 2020;158(2):322-340; DOI:10.1053/j.gastro.2019.06.048. Search in Google Scholar

21 Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, Chan FKL, Sung JJY, Yu J. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019;68(4):654-662; DOI:10.1136/gutjnl-2018-317178. Search in Google Scholar

22 Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7(6):e39743; DOI:10.1371/journal.pone.0039743. Search in Google Scholar

23 Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis. 2010;12(3):164-171; DOI:10.1111/j.1463-1318.2009.01814.x. Search in Google Scholar

24 Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis. 2011;53(9):870-878; DOI:10.1093/cid/cir609. Search in Google Scholar

25 Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306; DOI:10.1101/gr.126516.111. Search in Google Scholar

26 Ye X, Wang R, Bhattacharya R, Boulbes DR, Fan F, Xia L, Adoni H, Ajami NJ, Wong MC, Smith DP, Petrosino JF, Venable S, Qiao W, Baladandayuthapani V, Maru D, Ellis LM. Fusobacterium nucleatum subspecies Animalis influences proinflammatory cytokine expression and monocyte activation in human colorectal tumors. Cancer Prev Res (Phila). 2017;10(7):398-409; DOI:10.1158/1940-6207.CAPR-16-0178. Search in Google Scholar

27 Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320-329; DOI:10.1038/ismej.2011.109. Search in Google Scholar

28 Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12(8):782-786; DOI:10.1111/j.1469-0691.2006.01494.x. Search in Google Scholar

29 Dai Z, Zhang J, Wu Q, Chen J, Liu J, Wang L, Chen C, Xu J, Zhang H, Shi C, Li Z, Fang H, Lin C, Tang D, Wang D. The role of microbiota in the development of colorectal cancer. Int J Cancer. 2019;145(8):2032-2041; DOI:10.1002/ijc.32017. Search in Google Scholar

30 Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, Ng SC, Chan AWH, Chan FKL, Sung JJY, Yu J. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology. 2017;152(6):1419-1433.e5; DOI:10.1053/j.gastro.2017.01.009. Search in Google Scholar

31 Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015;6:20; DOI:10.3389/fmicb.2015.00020. Search in Google Scholar

32 He Z, Gharaibeh RZ, Newsome RC, Pope JL, Dougherty MW, Tomkovich S, Pons B, Mirey G, Vignard J, Hendrixson DR, Jobin C. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut. 2019;68(2):289-300; DOI:10.1136/gutjnl-2018-317200. Search in Google Scholar

33 Figliuolo VR, Dos Santos LM, Abalo A, Nanini H, Santos A, Brittes NM, Bernardazzi C, de Souza HSP, Vieira LQ, Coutinho-Silva R, Coutinho CMLM. Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis. Life Sci. 2017;189:29-38; DOI:10.1016/j.lfs.2017.09.014. Search in Google Scholar

34 Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661-672; DOI:10.1038/nrmicro3344. Search in Google Scholar

35 Barzak B., Hankus K., Parmar S., Wozniak S. The effect of physical activity on gut microbiota. A review. Med J Cell Biol. 2022;10(4):138-143; DOI:10.2478/ACB-2022-0021. Search in Google Scholar

36 Wozniak S, Nowinska K, Chabowski M, Dziegiel P. Significance of Irisin (FNDC5) expression in colorectal cancer. in vivo. 2022;36(1):180-188; DOI:10.21873/invivo.12689. Search in Google Scholar